Clinical Trials Logo
  1. Home
  2. Renal Failure, Chronic
  3. NCT00438295
  4. Details
NCT00438295 Clinical Trial

Temperature Control During Dialysis Treatment

Renal Failure, Chronic Clinical Trial

Official title:
Effect of Temperature Control During Dialysis Treatment With Glucose in Dialysis Water in Patients With Chronic Renal Failure

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00438295
Other study ID # MED.RES.2007.03.EBP
Secondary ID
Status Completed
Phase Phase 4
First received February 20, 2007
Last updated September 14, 2015
Start date August 2006
Est. completion date May 2007

Study information
Verified date September 2007
Source Regional Hospital Holstebro
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control

Description:

To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones

Recruitment information / eligibility
Status Completed
Enrollment 18
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Age > 18 years,

2. both men and women,

3. chronic renal failure and dialysis treatment for at least three months

Exclusion Criteria:

1. Heart failure,

2. Lung insufficiency,

3. Chronic liver disease,

4. Diabetes mellitus,

5. Malignant disease,

6. Nephrotic syndrome,

7. Lack of compliance,

8. Unwillingness til participate

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Procedure:
• temperature control

Locations
Country Name City State
Denmark Holstebro Hospital Holstebro

Sponsors (1)
Lead Sponsor Collaborator
Regional Hospital Holstebro

Country where clinical trial is conducted

Denmark, 

Outcome
Type Measure Description Time frame Safety issue
Primary Effect of temperature control on blood pressure, pulse rate and blod glucose during dialysis treatment
See also
  Status Clinical Trial Phase
Completed NCT00259025 - Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients Phase 2
Completed NCT00176059 - Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients Phase 0
Completed NCT00439023 - Glucose in Dialysis Water in Non-diabetics Phase 4
Completed NCT00438503 - Glucose in Dialysis Water in Diabetics With Chronic Renal Failure Phase 4
Completed NCT03904836 - Tobramycin Administered at the Beginning of Dialysis Phase 1
Not yet recruiting NCT02259296 - Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure N/A
Completed NCT00150891 - Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection N/A
Completed NCT01875523 - PK of Serelaxin in Severe Renal Impairment and ESRD Phase 1
Terminated NCT00664066 - DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
Withdrawn NCT00262353 - Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis N/A